首页>
外国专利>
PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED CNS-DERIVED PEPTIDES FOR PROMOTING NERVE REGENERATION AND PREVENTION OF NERVE DEGENERATION
PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED CNS-DERIVED PEPTIDES FOR PROMOTING NERVE REGENERATION AND PREVENTION OF NERVE DEGENERATION
展开▼
机译:包含经修饰的CNS衍生肽的药物组合物,用于促进神经再生和预防神经退行性变
展开▼
页面导航
摘要
著录项
相似文献
摘要
Compositions are provided for promoting nerve regeneration or reducing or inhibiting degeneration in the CNS or PNS to ameliorate the effects of injury or disease, comprising an active ingredient selected from: (a) a peptide obtained by modification of a self-peptide derived from a CNS-specific antigen, which modification consists in the replacement of one or more amino acid residues of the self-peptide by different amino acid residues, said modified CNS peptide still being capable of recognizing the T-cell receptor recognized by the self-peptide but with less affinity; (b) a nucleotide sequence encoding said peptide; (c) T cells activated by said peptide; and (d) any combination of (a) - (c). The peptide is preferably obtained by modification of the self-peptide p87-99 of MBP, more preferably, by replacing lysine 91 with glycine (G91) or alanine (A91) or by replacing proline 96 with alanine (A96).
展开▼